高血壓 高尿酸 慢性腎病 胰島素 https://2019medicinenote.blogspot.com/2019/12/blog-post_57.html . 糖尿病相關筆記~目錄 https://2019medicinenote.blogspot.com/2020/01/blog-post_4.html

2020年5月2日 星期六

糖尿病合併慢性腎病/腎衰竭/腎功能不良/透析患者的藥物選擇

2025-12-10

初期CKD教育訓練課程二:慢性腎臟病之追蹤與治療主講人: 吳美儀 醫師



DPP4i
Onglyza (Saxagliptin) F.C Tab. 5mg CCR<30 2.5mg QD 但洗腎患者不建議使用
Trajenta (Linagliptin)不用調整劑量
Galvus (vildagliptin)eGFR < 50 劑量 50mg qd. 
Januvia 100 mg (sitagliptin) eGFR 45-60 不用調整劑量. 

Diabetes treatment in patients with renal disease: Is the landscape clear enough?

PRESCRIBING GUIDANCE IN PATIENTS WITH RENAL IMPAIRMENT TREND-UK: the diabetes nursing pioneers WWW.TREND-UK.ORG INFO@TREND-UK.ORG  @_TRENDUK TRAINING, RESEARCH AND EDUCATION FOR NURSES IN DIABETES Kindly provided through a PCDS and TREND-UK collaboration - July 2017

2016-09-30 藥學雜誌電子報

CKD stage 4-5 eGFR <30
第四及第五期慢性腎病, 不需調整劑量的抗糖尿病藥物
Pioglitazone 腎衰竭要小心使用 
Trajenta (Linagliptin)不用調整劑量


另一篇說 Gliclazide 和  clipizide 在腎衰竭是可以用的.
Gliclazide
Gliclazide is metabolized by the liver to inactive metabolites that are eliminated in the urine. Thus, gliclazide causes less hypoglycemia than other sulfonylureas. In CKD sage 1, 2, 3 (eGFR > 30 mL/min) gliclazide can be used. There are no data in patients with severe CKD but according to its metabolism the use (in reduced dose) of gliclazide is also permitted in these subjects[19].
Glipizide
Glipizide also does not need dose adjustment in severe and moderate renal disease and can be used safely. (The only caution remains the risk of hypoglycemia).

Pioglitazone: Glitis 30 mg. Actos 15 mg. TZD. 水腫.體液滯留 Cr>4 不用調整劑量
但洗腎患者不建議使用 TZD



Onglyza (Saxagliptin) F.C Tab. 5mg CCR<30 2.5mg QD 但洗腎患者不建議使用 
Trajenta (Linagliptin) 不用調整劑量 
Galvus (vildagliptin) eGFR < 50 劑量 50mg qd. 

CANAGLU 100MG Canagliflozin eGFR < 45 需停用 (Canaglu®可拿糖膜衣錠)

FORXIGA 10MG dapagliflozin eGFR< 45 需停用
 
JARDIANCE 25MG  empagliflozin eGFR<45 需停用
  








沒有留言:

張貼留言

幼兒專責醫師-新生兒黃疸

2026-03-26 09:16AM 衛生福利部-幼兒專責醫師實務參考手冊電子版 圖片: 台灣新生兒科醫學會-新生兒延長性黃疸處置建議 2018.05.04 測定『直接及總膽紅素並求其比值』:當新生兒的黃疸超過出生後 14 天時,建議於 30 天大之前,至少檢測一次血中直接及總膽...